KR0157757B1 - Separation method for bifidobacterium which has acid tolerance - Google Patents

Separation method for bifidobacterium which has acid tolerance

Info

Publication number
KR0157757B1
KR0157757B1 KR1019960007850A KR19960007850A KR0157757B1 KR 0157757 B1 KR0157757 B1 KR 0157757B1 KR 1019960007850 A KR1019960007850 A KR 1019960007850A KR 19960007850 A KR19960007850 A KR 19960007850A KR 0157757 B1 KR0157757 B1 KR 0157757B1
Authority
KR
South Korea
Prior art keywords
bifidobacterium
medium
culture
inoculated
bile
Prior art date
Application number
KR1019960007850A
Other languages
Korean (ko)
Other versions
KR970065706A (en
Inventor
지근억
정현서
이명자
김영배
Original Assignee
지근억
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지근억 filed Critical 지근억
Priority to KR1019960007850A priority Critical patent/KR0157757B1/en
Publication of KR970065706A publication Critical patent/KR970065706A/en
Application granted granted Critical
Publication of KR0157757B1 publication Critical patent/KR0157757B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045Culture media therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

본 발명은 자연물을 혐기조건하에 비피도박테리움 선택배지에 접종하여 배양하고, 상기 얻어진 배양액을 다시 최적 비피도박테리움 선택배지에 재접종하여 강화 계대배양함으로써 생균수를 증가시키고, 얻어진 강화배양된 배양액을 강산성으로 조절된 비피도박테리움 선택배지에 접종하여 배양하고, 상기 산성 배지에서 얻어진 배양액을 약산성으로 조절된 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액을 최적 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액에서 생존 비피도박테리움의 존재를 확인하고, 상기 배양액을 고농도 담즙이 함유된 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액을 저농도 담즙이 함유된 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액으로부터 생존 비피도박테리움을 분리하는 단계를 포함하는 내산성 및 내담즙성 비피도박테리움의 분리방법에 관한 것이다. 본 발명의 방법에 따라 자연물로부터 비피도박테리움을 스크리닝하였을 때 내산성(acid tolerance 및 resistance) 및 내담즙성을 갖는 균주를 효과적으로 분리할 수 있다.The present invention is inoculated with natural material in Bifidobacterium selective medium under anaerobic conditions, and re-inoculated the obtained culture medium to optimal Bifidobacterium selective medium to increase the number of viable cells to increase the viable cell number, and obtained reinforced culture The culture was inoculated in a strongly acidic Bifidobacterium selective medium and cultured, and the culture medium obtained in the acidic medium was inoculated in a slightly acidic Bifidobacterium selective medium and cultured, and the obtained culture was selected for optimal Bifidobacterium selection. Inoculate the medium and incubate, confirm the presence of vivid bacterium in the culture medium obtained, inoculate the culture medium into the Bifidobacterium selective medium containing a high concentration of bile, and culture the obtained broth containing low concentration bile Inoculation was carried out in the culture medium of gambling bacterium, and viability was obtained from the obtained culture solution. It relates to a method for separating acid and bile resistant Bifidobacterium comprising the step of separating the bacterium. When screening Bifidobacterium from natural products according to the method of the present invention, it is possible to effectively isolate strains having acid tolerance and resistance and bile resistance.

Description

내산성 및 내담즙성 비피도박테리움의 분리방법Separation method of acid and bile resistant Bifidobacterium

본 발명은 내산성 및 내담즙성 비피도박테리움의 제조방법에 관한 것이다.The present invention relates to a process for preparing acid and bile resistant Bifidobacterium.

인간이나 동물에게 살아있는 미생물을 분말 또는 발효산물의 형태로 투여하였을 때, 장내 미생물의 바람직한 균형과 그들의 특성을 증진시키며 숙주에게 유익한 작용을 일으키는 경우 이들을 프로바이오틱스(probiotics)라 한다(O'sullivan M. G., et al., Probiotic bacteria : myth or reality?, Trends Food Sci. Technol., 31, pp. 309-314(1992)).When living microorganisms are administered to humans or animals in the form of powders or fermented products, they promote the desired balance of their intestinal microorganisms and their properties and produce beneficial effects on the host. These are called probiotics (O'sullivan MG, et. al., Probiotic bacteria: myth or reality ?, Trends Food Sci. Technol., 31, pp. 309-314 (1992)).

프로바이오틱스는 젖산균에 한정된 것은 아니지만 매치니코프(Mechinicoff)에 의해 유산균 음료의 유익작용이 처음으로 언급된 이후 식품첨가물로서의 미생물의 역할에 대한 관심이 끊이지 않고 있으며, 식품산업, 동물사료, 약품제조 등에 미생물의 도입하는 기술이 다양하게 시도되고 있다.Probiotics are not limited to lactic acid bacteria, but interest in the role of microorganisms as food additives has been continually observed since the first beneficial effect of lactic acid beverages was mentioned by Mechinicoff. There are various attempts to introduce the technology.

비피도박테리움 균주는 인체의 장내 미생물중 우세 균총의 하나로서, 감염에 대한 저항성, 항암효과, 혈액내 콜레스테롤 함량의 저하 및 정장 효과와 같은 유익작용이 보고된 바 있다(Hentges D. J., Human intestinal microflora in health and disease, Academic Press, pp. 241-261, (1983); Hosono A., Wardojo R. and Otani H., lnhibitory effects of lactic acid nacteria from fermented milk on the mutagenicities of volatile bitrosoamines, Agr. Biol. Chem. 54, 7, pp. 1639-1643 (1990)). 따라서, 프로바이오틱스로서의 비피도박테리움과 같은 젖산균의 우수 개량균주를 개발하는 것이 중요한 과제로 부각되고 있다(Klaenhammer T. R., Microbial considerations in selection and preparation of Lactobacillus strains for use as dietary adjuncts., J. Dairy Sci., 65, pp. 1339-1349 (1982)).Bifidobacterium strain is one of the predominant bacterial flora of the human intestinal microorganisms and has been reported to have beneficial effects such as resistance to infection, anticancer effect, lowering blood cholesterol content and intestinal effect (Hentges DJ, Human intestinal microflora) in health and disease, Academic Press, pp. 241-261, (1983); Hosono A., Wardojo R. and Otani H., lnhibitory effects of lactic acid nacteria from fermented milk on the mutagenicities of volatile bitrosoamines, Agr. Biol. Chem. 54, 7, pp. 1639-1643 (1990)). Therefore, the development of excellent strains of lactic acid bacteria such as Bifidobacterium as probiotics has emerged as an important task (Klaenhammer TR, Microbial considerations in selection and preparation of Lactobacillus strains for use as dietary adjuncts., J. Dairy Sci. , 65, pp. 1339-1349 (1982)).

이와 같이 비피도박테리움의 다양한 유익작용을 식품산업에 이용하는 응용예가 늘어가고 있으나, 이 균주는 절대 혐기성균이라는 점과 경구 섭취하였을 때 공복시 가혹한 환경, 즉 pH가 3 이하로 내려가는 위장과 소장에서 분비되는 소화효소 및 담즙산에 의해 생육이 저해되어 대장에 도달하는 생균수가 감소할 뿐만 아니라 장내 정착률이 저하된다는 문제점이 지적되고 있다(Mitsuoka T., Microbes in the intestine, Our lifelong partners, pp. 1-18, 1989). 실제로 현재 시판되고 있는 비피더스 발효 우유를 섭취하였을 때 대장에 도달하여 정착하는 비피도박테리움의 생균수가 숙주에 유익한 작용을 할 정도의 충분한 양이 되지 못한다고 보고되고 있다(Roy D. et al., Uncoupling of growth and acids production in Bifidobacterium spp. J. Dairy Sci., 73 pp. 1478-1484, (1990)). 또한 베라다 등은 비피더스 발효음료의 제조에 있어서 내산성 보유 균주의 선발의 필요성을 과제로 제시하고 있다(Berrada et al., Bifidobacterium from fermented milks, Survival during gastric transit, J. Dairy Sci. 14, pp. 409-413 (1991)).Increasingly, the application of various benefits of Bifidobacterium to the food industry is increasing. However, this strain is an absolute anaerobic bacterium and secreted from the stomach and small intestine where the pH is lowered to 3 or lower on an empty stomach when taken orally. It is pointed out that the growth rate is inhibited by digestive enzymes and bile acids, which reduce the number of viable bacteria reaching the large intestine and decrease the intestinal settlement rate (Mitsuoka T., Microbes in the intestine, Our lifelong partners, pp. 1-18 , 1989). In fact, it is reported that the biomass of Bifidobacterium that reaches and colonizes the large intestine when ingested commercially available bifidus fermented milk is not sufficient to have a beneficial effect on the host (Roy D. et al., Uncoupling of growth and acids production in Bifidobacterium spp.J. Dairy Sci., 73 pp. 1478-1484, (1990)). In addition, Verada et al. Proposed the need for selection of acid resistant strains in the production of fermented beverages (Berrada et al., Bifidobacterium from fermented milks, Survival during gastric transit, J. Dairy Sci. 14, pp. 409-413 (1991).

비피도박테리움을 개량하기 위한 노력으로서, 한국 특허공고 제92-1375 호 (1992. 2.11. 공고)는 돼지와 소의 내장을 분쇄하여 생리적 식염수에 현탁시킨 후 BCP아가 배지에 도말하여 37℃에서 24시간 배양함으로써 새로운 젖산균을 얻었다고 보고하였다. 그러나, 이렇게 얻어진 균주는 아직 내산성 및 내담즙성에 있어서 충분하다고 할 수 없으며, 장내 정착률이 더욱 향상된 균주를 개발할 필요가 있다.In an effort to improve Bifidobacterium, Korean Patent Publication No. 92-1375 (February 11, 1992) discloses the pulverization of pigs and cattle, suspended in physiological saline, and then smeared on BCP agar medium at 24 It was reported that new lactic acid bacteria were obtained by time incubation. However, the strains thus obtained are not yet sufficient in acid resistance and bile resistance, and there is a need to develop strains with improved intestinal fixation rate.

본 발명은 이와 같은 종래 기술의 문제점을 감안하여 안출된 것으로, 그 목적은 내산성 및 내담즙성을 갖는 우수한 비피도박테리움의 분리방법을 제공하는 것이다.The present invention has been made in view of the problems of the prior art, and its object is to provide an excellent method for separating Bifidobacterium having acid resistance and bile resistance.

상기와 같은 본 발명의 목적은, 자연물을 혐기조건하에 비피도박테리움 선택배지에 접종하여 배양하고, 상기 얻어진 배양액을 다시 최적 비피도박테리움 선택배지에 재접종하여 강화 계대배양함으로써 생균수를 증가시키고, 얻어진 강화배양된 배양액을 강산성으로 조절된 비피도박테리움 선택배지에 접종하여 배양하고, 상기 산성 배지에서 얻어진 배양액을 최적 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액에서 생존 비피도박테리움의 존재를 확인하고, 상기 배양액을 고농도 담즙이 함유된 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액을 저농도 담즙이 함유된 비피로박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액으로부터 생존 비피도박테리움을 분리하는 단계를 포함하는 내산성 및 내담즙성 비피도박테리움의 분리방법에 의해 달성될 수있다.The purpose of the present invention as described above, by inoculating the natural product in the Bifidobacterium selection medium under anaerobic conditions, and re-inoculated the obtained culture medium in the optimum Bifidobacterium selection medium to increase the viable cell number The cultured cultures were inoculated in a strongly acidified Bifidobacterium selective medium, and the culture medium obtained in the acidic medium was inoculated in an optimal Bifidobacterium selective medium and cultured. The presence of terium was confirmed, the culture was inoculated in a bifidobacterium selective medium containing a high concentration of bile, and the obtained culture was inoculated in a bipyrobacterium selective medium containing a low concentration of bile, followed by culture. Acid and bile resistant BP comprising the step of separating the viable Bifidobacterium from It can be achieved by a method of separating tumefaciens.

비피도박테리움을 배양할 때 사용되는 선택배지로는 공지된 여러 종류의 배지가 사용될 수 있다. 대표적인 예로서는, BS(Mitsuoka T., A color atlas of anaerobic bacteria 2nd ed., Tokyo (1984)), NPNL(Teraguchi S. et al., Japanese Journal of Bacteriology, 33, 753 (1978)), 또는 GL(Hirokazu l. et al., Bifidobacteria Microflora, 12, 39 (1993)) 등을 거론할 수 있다. 그러나 본 출원인에 의해 개발된 TP 배지가 본 발명의 목적에 가장 바람직하다. TP 배지는 트립티케이스, 프로테우스 펩톤, 황산암모늄, 칼륨, 인산염, 시스테인, 전이 갈락토올리고당 및 염화프로피온으로 구성되어 있으며, 비피도박테리움의 선택배지로서 잡균의 번식을 억제하고 비피도박테리움 균주의 증식을 촉진시키는 특성을 나타낸다(지근억 등, 한국식품과학회지 26(5), 526-531, (1994)).As the selection medium used for culturing Bifidobacterium, various kinds of known media may be used. Representative examples include BS (Mitsuoka T., A color atlas of anaerobic bacteria 2nd ed., Tokyo (1984)), NPNL (Teraguchi S. et al., Japanese Journal of Bacteriology, 33, 753 (1978)), or GL ( Hirokazu l. Et al., Bifidobacteria Microflora, 12, 39 (1993)). However, TP medium developed by the applicant is most preferred for the purposes of the present invention. TP medium is composed of trypticase, proteus peptone, ammonium sulfate, potassium, phosphate, cysteine, transition galactooligosaccharide and propion chloride.It is a selective medium of Bifidobacterium and inhibits the growth of various bacteria and Bifidobacterium strains. Has been shown to promote the proliferation of erythematosus (Lee, et al., Korean Food Science Society 26 (5), 526-531, (1994)).

비피도박테리움은 자연에 널리 분포하는 미생물로서, 여러 종류의 자연물로부터 획득할 수 있다. 대표적으로는 동물의 분변, 우유, 동물의 대장 등을 예시할 수 있으며, 사람의 분변에서도 우수 균주를 분리할 수 있다.Bifidobacterium is a microorganism widely distributed in nature and can be obtained from various kinds of natural products. Representative examples of the animal feces, milk, the large intestine of the animal, etc. can be exemplified, and excellent strains can also be isolated from human feces.

분 발명에 있어서, 먼저 비피도박테리움이 포함된 자연물을 선택배지에 접종하여 배양한다. 이 때 비피도박테리움은 절대 혐기성균이므로 혐기조건을 유지해여야 하며 따라서 자연물의 채취 즉시 배지를 가득 채운 튜브에 접종하는 것이 바람직하다.In the present invention, first, the natural material containing Bifidobacterium is inoculated in a selective medium and cultured. At this time, Bifidobacterium is an absolute anaerobic bacterium, so it should be maintained in anaerobic conditions. Therefore, it is preferable to inoculate a tube filled with a medium immediately after collecting natural products.

이와 같이 자연물을 비피도박테리움 선택배지에 접종한 다음 약 37℃에서 약 12시간 배양한다. 배양 시간은 특정된 것은 아니나 접종된 비피도박테리움의 증식이 이루어지고 잡균의 생육이 억제되는데 필요한 시간 동안 배양은 진행한다.As such, the natural material is inoculated into Bifidobacterium selective medium and then incubated at about 37 ° C. for about 12 hours. The incubation time is not specified, but the incubation proceeds for the time necessary for the propagation of the inoculated Bifidobacterium and the growth of various bacteria.

이렇게 얻어진 비피도박테리움이 포함된 배양액을 최적 선택배지에 접종하여 계대배양함으로써 균주를 강화시킨다. 즉, 계대배양은 6회 실시하는 것이 바람직하며, 이와 같은 강화배양에 의해 비피도박테리움 균주의 증식을 도모할 수 있다. 배양조건은 역시 혐기적 분위기에서 약 37℃로 진행하며 시간은 계대배양마다 약 12시간을 유지한다.The strain is enriched by inoculating the medium containing the Bifidobacterium thus obtained in an optimal selection medium and subcultured. That is, it is preferable to carry out the subculture 6 times, and the growth of the Bifidobacterium strain can be achieved by such an enrichment culture. The culture conditions also proceed to about 37 ° C. in anaerobic atmosphere and the time is maintained for about 12 hours per subculture.

강화배양된 배양액을 강산성으로 조절된 비피도박테리움 선택배지에 접종하여 약 37℃에서 약 2시간 내지 3시간 배양한다. 이를 위하여 선택배지를 강산성으로 먼저 조절하여야 하며, 따라서 선택배지에 산(HCl 등)을 첨가하여 pH를 약 1.5 내지 2.5로 조절한다. 강산성 조건에서 실질적으로 모든 균의 증식은 억제되며, 특히 내산성이 취약한 균들은 모두 사멸하게 된다.Enriched cultures are inoculated in a strongly acidified Bifidobacterium selective medium and incubated at about 37 ° C. for about 2 hours to 3 hours. To this end, the selective medium must first be adjusted to strong acidity, so that the pH is adjusted to about 1.5 to 2.5 by the addition of acid (HCl, etc.) to the selective medium. Under strong acid conditions, the growth of virtually all bacteria is suppressed, and in particular, all bacteria that are weak in acid resistance are killed.

얻어진 배양액을 다시 약산성으로 조절된 선택배지에 접종하기 이전에, 균주를 최적 배지에서 배양하는 것이 바람직하다, 즉, 강산성 배지에서의 배양에 의해서 균체수가 감소되고 생존력이 약화되었으므로, 약산성 배지에 접종하기 이전에 최적 배지에 접종하여(약 1% 수준) 약 12시간 배양함으로써 균체수를 증가시키고 활성을 강화시키는 것이 필요하다.Prior to inoculation of the obtained culture medium into a slightly acid-adjusted selection medium, it is preferable to cultivate the strain in an optimal medium, that is, inoculation into a weakly acidic medium because the cell count is reduced and viability is reduced by culturing in a strong acidic medium. It is necessary to increase the number of cells and enhance the activity by inoculating the optimal medium (about 1% level) and incubating for about 12 hours.

상기 최적 배지에서 배양한 배양액을 다시 약산성 선택배지에 접종하여 약 37℃에서 약 5 내지 10시간 배양한다. 이 때 배지의 pH는 HCl을 첨가하여 약 3.5 내지 4.5로 조절한다.The culture medium incubated in the optimum medium is inoculated again in a weakly acidic selective medium and incubated at about 37 ° C. for about 5 to 10 hours. At this time, the pH of the medium is adjusted to about 3.5 to 4.5 by the addition of HCl.

상기 단계에 의해 강산성과 약산성 조건 배양을 거친 후 배양액을 최적 배지에 접종하여 다시 약 37℃에서 약 12시간 배양함으로써 균의 증식과 활성화를 시킨 다음에, 생존한 비피도박테리움의 존재 여부를 확인한다. 확인하는 방법으로는 그램 염색하여 형태(그램 양성 간균의 굴곡된 형태)를 관찰하거나, Scardovi 방법으로 F6PPK 실험을 할 수도 있다(Scardovi V. et al., The fructose-6-phosphate shunt as a peculiar pattern of hexose degradation in the genus Bifidobacterium. Ann. Microbial. Enzimol., 15, pp. 19-29 (1965)).After culturing strong acid and weak acid conditions by the above steps, the culture medium is inoculated into an optimum medium and incubated for about 12 hours at 37 ° C. again to proliferate and activate bacteria, and then confirm the presence of Bifidobacterium surviving. do. For confirmation, gram staining can be used to observe the form (curved form of gram-positive bacillus), or F6PPK experiments can be performed using the Scardovi method (Scardovi V. et al., The fructose-6-phosphate shunt as a peculiar pattern of hexose degradation in the genus Bifidobacterium.Ann. Microbial.Enzimol., 15, pp. 19-29 (1965)).

비피도박테리움 균주의 존재가 확인된 배양액을 고농도 담즙이 함유된 비피도박테리움 선택배지에 접종하여 배양한다(37℃, 2-3 시간). 이 때 배지의 담즙의 농도는 약 1내지 2%로 조절한다. Oxgall power로서 담즙 1% 용액은 담즙 10%농도에 해당된다. 생성된 배양액에 연속해서 담즙 스트레스를 가하기 이전에, 균체의 증식과 활성의 증가를 위하여 최적 선택배지에 접종하려 약 37℃에서 배양(약 12시간)하는 것이 바람직하다.The culture medium in which the presence of the Bifidobacterium strain is confirmed is inoculated in a Bifidobacterium selective medium containing high concentration of bile (37 ° C., 2-3 hours). At this time, the concentration of bile in the medium is adjusted to about 1 to 2%. As oxgall power, 1% bile solution corresponds to 10% bile concentration. Before successively applying bile stress to the resulting culture, it is desirable to incubate (about 12 hours) at about 37 ° C. to inoculate the optimal selection medium for the growth and activity of the cells.

얻어진 배양액을 다시 저농도 담즙이 함유된 비피도박테리움 선택배지에 접종하여 배양한다. 이 때 담즙의 농도는 약 0.5 내지 1%로 조절하고 약 37℃에서 5 내지 7시가 배양한다.The obtained culture solution is again inoculated in a Bifidobacterium selective medium containing a low concentration of bile and cultured. At this time, the concentration of bile is adjusted to about 0.5 to 1% and incubated at about 37 ° C. for 5 to 7 hours.

이렇게 얻어진 배양액을 최적 비피도박테리움 선택배지에 접종하여 배양(약 37℃에서 약 12시간)하여 균체의 증식과 활성의 증진을 도모한다. 이 배양액을 미쯔오카의 방법(Mitsuoka T., Recent trends in research on intestinal flora, Bifidobacterium Microflora, 1, pp. 3-4, (1982))에 따라 희석하여 희석액을 최적 배지에 도말하고 혐기조건으로 37℃에서 48 시간 내지 72 시간 배양하여 생존 비피도박테리움을 분리한다.The culture solution thus obtained is inoculated in an optimal Bifidobacterium selective medium and cultured (about 12 hours at about 37 ° C.) to increase the growth and activity of the cells. Dilute this culture according to the method of Mitsuoka (Mitsuoka T., Recent trends in research on intestinal flora, Bifidobacterium Microflora, 1, pp. 3-4, (1982)) to spread the diluted solution to the optimal medium and to 37 ° C under anaerobic conditions. Survival Bifidobacterium is isolated by incubation for 48 to 72 hours.

이하, 실시예에 의거하여 본 발명을 상세히 설명한다.EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail based on an Example.

[실시예 1]Example 1

자연물로부터 비피도박테리움을 분리Separation of Bifidobacterium from Natural Products

건강한 성인 50명과 유아 20명에게 강화배양용 배지인 TP를 가득 채운 스크류 캡 튜브(screw cap tube)를 제공하고 분변 약 0.5g을 배지에 접종한 후 실험실로 이송하였다. TP배지의 조성은 다음 표1에 제시한다.50 healthy adults and 20 infants were provided with a screw cap tube filled with TP, a reinforcing culture medium, and about 0.5 g of fecal inoculated into the medium was transferred to a laboratory. The composition of TP medium is shown in Table 1 below.

1) TOS : transgalactooligosaccharide (일본 야쿠르트사 제품)1) TOS: transgalactooligosaccharide (manufactured by Yakult, Japan)

※최종 pH는 7.0로 조정※ The final pH is adjusted to 7.0

상기 분변을 접종한 배지를 37℃에서 12시간 배양하고 다시 신선한 TP 배지에 재접종하여 37℃에서 6회 계대배양하였다. 계대배양후 배양액을 소량 취하여 그램 염색을 한 후 현미경으로 관찰한 결과, 비피도박테리움의 수가 증가되었음을 확인하였다. 멸균된 TP 배지에 4N HCl을 첨가하여 pH를 2로 조절한 후, 상기 계배양된 배양액을 참가하여 37℃에서 2시간 배양하였다. 배양이 끝난 후 배양액을 1% 수준으로 최적 TP 배지에 접종하여 37℃에서 12시간 배양하였다.The fecal inoculated medium was incubated at 37 ° C. for 12 hours, re-inoculated with fresh TP medium, and subcultured at 37 ° C. six times. After passage, a small amount of the culture medium was taken, stained with gram, and observed under a microscope. As a result, the number of Bifidobacterium was increased. After the pH was adjusted to 2 by adding 4N HCl to the sterilized TP medium, the incubated culture was added and incubated at 37 ° C. for 2 hours. After the incubation, the culture solution was inoculated in optimal TP medium at 1% level and incubated at 37 ° C. for 12 hours.

상기 배양액을 HCl을 첨가하여 pH를 4로 조절한 TP 배지에 접종하여 37℃에서 6시간 배양하였다. 이렇게 얻어진 배양액을 최적 TP 배지에 접종하여 37℃에서 12시간 배양하였다. 배양액을 그램 염색하여 현미경으로 관찰함으로써 비피도박테리움의 존재를 확인하였다. 상기 방법에 의해 비피도박테리움의 존재가 확인된 시료에 대해 그 배양액을 1.5% 담즙이 함유된 TP 배지에 접종하고 37℃에서 2시간 배양하였다. 생성된 배양액을 담즙이 첨가되지 않은 TP 배지에 1% 수준으로 접종하여 37℃에서 12시간 배양하였다. 다시 배양액을 1% 담즙이 함유된 TP 배지에 접종하여 37℃에서 6시간 배양한 다음, 배양액을 최적 TP 배지에 접종하고 37℃에서 12시간 배양하였다.The culture was inoculated in TP medium adjusted to pH 4 by the addition of HCl and incubated at 37 ° C. for 6 hours. The culture solution thus obtained was inoculated in optimal TP medium and incubated at 37 ° C for 12 hours. The presence of bifidobacterium was confirmed by gram staining of the culture and observing under a microscope. The sample was inoculated in TP medium containing 1.5% bile and incubated for 2 hours at 37 ° C for the sample confirmed the presence of Bifidobacterium by the above method. The resulting culture was inoculated at 1% level in TP medium without bile and incubated at 37 ° C. for 12 hours. Again, the culture solution was inoculated in TP medium containing 1% bile and incubated at 37 ° C. for 6 hours, and then the culture solution was inoculated in optimal TP medium and incubated at 37 ° C. for 12 hours.

얻어진 배양액을 미쯔오카 방법에 따라 혐기성균 희석용액을 사용하여 10-8까지 희석한 후, 각각의 희석액에서 100㎕를 취하여 TP 배지에 도말하였다. 혐기성 희석액의 조성은 다음 표2와 같다.The obtained culture solution was diluted to 10 −8 using an anaerobic bacteria dilution solution according to the Mitsoka method, and then 100 μl of each diluted solution was plated on TP medium. The composition of the anaerobic diluent is shown in Table 2 below.

1) 염 용액 : 증류수 100㎖에 K2HPO40.47g, NaCl 1.18g, (NH4)2SO41.20g, CaCl20.12g 및 MgSO4H2O 0.25g을 용해시켜 제조한다.1) Salt solution: prepared by dissolving 0.47 g of K 2 HPO 4 , 1.18 g of NaCl, 1.20 g of (NH 4 ) 2 SO 4 , 0.12 g of CaCl 2 and 0.25 g of MgSO 4 H 2 O in 100 ml of distilled water.

이 배지를 혐기 용기(anaerobic jar)에서 산소를 질소로 치환(Gas Pack system과 Anaerobic glove box를 이용)하여 혐기 환경을 조성한 후, 37℃에서 48시간 내지 72시간 배양하였다.This medium was prepared by replacing oxygen with nitrogen in an anaerobic jar (using a Gas Pack system and Anaerobic glove box) to form an anaerobic environment, and then incubating at 37 ° C. for 48 to 72 hours.

[실시예 2]Example 2

비피도박테리움의 확인(F6PPK 시험)Confirmation of Bifidobacterium (F6PPK Test)

상기 실시예1의 혐기 용기(anaerobic jar)에서 배양한 고체 TP 배지에서 비피도박테리움으로 추정되는 단일 집락을 취하여 1차적으로 그램 염색을 한 후 현미경으로 관찰하여 비피도박테리움 균주임을 확인하였다. 상기 균주를 BHI 액체 및 고체배지에 접종하여 활성화시킨 균액으로 Scardovi의 방법에 의하여 F6PPK 실험을 실시하였다. 노란색의 반응액은 네가티브로, 보라색의 반응액은 포지티브로 판정하였다.In a solid TP medium cultured in the anaerobic jar of Example 1, a single colony presumed to be Bifidobacterium was taken, and gram staining was performed first, and then observed under a microscope to confirm that it was a Bifidobacterium strain. F6PPK experiment was performed by Scardovi's method with the fungus inoculated by activating the strain in BHI liquid and solid medium. The reaction solution in yellow was negative, and the reaction solution in purple was positive.

[실시예 3]Example 3

비피도박테리움의 내산성(acid tolerance) 측정Determination of Acid Tolerance of Bifidobacterium

상기 실시예1에 있어서, 각 배양 단계에서 취한 비피도박테리움 균주를 다음 표3의 조성을 갖는 MRS 액체배지에서 활성화시킨 후, 4N HCl을 이용하여 pH를 7.5 및 4.5로 조절한 MRS 액체배지에 1% 수준으로 접종하였다. 접종후 3시간 간격으로 24시간 동안 흡광도(Spectronic 20, Miton Roy C0.)를 620nm에서 측정하였다. 각 테스트는 3회 반복시험하였다. 결과를 다음 표4에 표시한다.In Example 1, after activating the Bifidobacterium strains taken in each culture step in the MRS liquid medium having the composition shown in Table 3, 1 to the MRS liquid medium adjusted to pH 7.5 and 4.5 using 4N HCl. Inoculated at the% level. Absorbance (Spectronic 20, Miton Roy C0.) Was measured at 620 nm for 24 hours at 3 hour intervals after inoculation. Each test was repeated three times. The results are shown in Table 4 below.

상기 표4는 생장곡선의 작성을 위하여 흡광도를 측정함으로써 균의 성장속도를 상대적인 값으로 표시한 것으로서, 최소값 0.0으로부터 최대값 1.5를 범위로하여 0.0-0.3은 유도기, 0.3-0.9는 대수기, 0.9 이상은 정지기를 나타낸다. 본 발명의 방법에 따라 실시예1에서 분리 선발된 균주시료 HJ, Sl 및 SJ는 일반적인 분리방법으로 분변에서 직접 취해진 대조균주 l1 및 J1(분변으로부터 스트레스를 가함이 없이 TP 선택배질 분리한 균주)에 비해 높은 내산성을 갖고 있음을 알 수 있다.Table 4 shows the growth rate of the bacteria as a relative value by measuring the absorbance for the development of the growth curve, with 0.0-0.3 being induction, 0.3-0.9 being logarithmic, 0.9 The above shows a stopper. Strain samples HJ, Sl, and SJ isolated and separated in Example 1 according to the method of the present invention to the control strains l1 and J1 (strains isolated from TP-selective strain without stress from feces) taken directly from feces as a general separation method. It can be seen that it has a high acid resistance.

[실시예 4]Example 4

비피도박테리움의 내산성(acid tolerance) 측정Determination of Acid Tolerance of Bifidobacterium

0.05N의 sodium phosphate, dibasic에 cysteine·HCl을 0.05% 되게 첨가한 후 질소가스로 치환시며 기본 배지를 만들었다. 이 기본배지를 4N HCl을 이용하여 pH를 7, 3 및 2로 조정하여 멸균한 배양액에 선발된 균주를 1% 수준으로 접종하였다.0.05N sodium phosphate and dibasic were added to 0.05% of cysteine.HCl, followed by substitution with nitrogen gas to make a basic medium. The base medium was inoculated at 1% level in selected strains in sterilized culture by adjusting the pH to 7, 3 and 2 using 4N HCl.

접종후 출발시점, 0.5, 1 및 2시간대의 배양액을 100㎕ 취하여 혐기성 희석액에서 미쯔오카의 방법에 의하여 희석한 후 BL고체 배지(표 5 참조)에 도말하여 혐기용기에서 혐기적으로 36-48시간 배양한 후 생균수를 측정하였다. 각 선발균주의 내산성은 pH별 생균수의 변화로 비요하였다. 각 실험은 2회 반복으로 실시하였다. 결과를 다음 표6에 표시한다.At the start of inoculation, 100 µl of the culture solution for 0.5, 1 and 2 hours was taken and diluted in the anaerobic dilution solution by the method of Mitsoka, and then plated on BL solid medium (see Table 5) for 36-48 hours anaerobicly in the anaerobic vessel. After incubation, the number of viable cells was measured. Acid resistance of each strain was significantly affected by the change of viable cell number by pH. Each experiment was conducted in two replicates. The results are shown in Table 6 below.

※ 최종 pH는 7.5로 조성한다.※ The final pH is set at 7.5.

1) 간 추출물(liver extract)의 제조법 : 간장 분말 10g을 170㎖ 증류수에 넣은 후 50-60℃ 항온 수조에서 1시간 동안 침출한 후 100℃로 가열하여 여과지로 거른다.1) Preparation of liver extract (liver extract): 10g soy sauce powder in 170ml distilled water and leached in a 50-60 ℃ constant temperature water bath for 1 hour, and then heated to 100 ℃ to filter by filter paper.

2) A 용액 : KH2PO425g + K2HPO425g + 증류수 250㎖2) A solution: KH 2 PO 4 25g + K 2 HPO 4 25g + distilled water 250ml

3) B 용액 : MgSO4·7H2O 10g + FeSO4·7H2O 0.5g + NaCl 0.5g + MnSO40.337g + 증류수 250㎖3) B solution: MgSO 4 7H 2 O 10g + FeSO 4 7H 2 O 0.5g + NaCl 0.5g + MnSO 4 0.337g + Distilled water 250ml

[실시예 5]Example 5

비피도박테리움의 내담즙성 시험Bile Resistance Test of Bifidobacterium

0.05N의 sodium phosphate, dibasic에 cysteine·HCl을 0.05%되도록 첨가한 후 질소가스로 치환시켜 기본배지를 만들었다. 기본배지에 담즙(bile)을 0%, 0.5% 및 1%되도록 첨가하여 알루미늄 캡으로 밀봉할 수 있는 튜브에 가득 채운 후 멸균시켰다.0.05N sodium phosphate and dibasic were added to 0.05% of cysteine.HCl, and then replaced with nitrogen gas to make a basic medium. Bile was added to the base medium so that 0%, 0.5% and 1% were filled in a tube that could be sealed with an aluminum cap, and then sterilized.

배양액에 선발된 균주 및 대조 균주를 1%수준으로 접종한 후 37℃의 항온배양기에서 배양하였다. 배양중 출발시점 1, 3, 8 및 12시간대의 배양액 100㎕를 취하여 혐기성 희석액에서 미쯔오카의 방법에 따라 희석한 후 BL 고체배지에 도말하여 혐기용기에서 혐기적으로 36 내지 48시간 배양한 후 생균수를 측정하였다. 각 선발균주의 내담즙성은 담즙의 함유량에 대한 생균수의 변화로 비교하였다. 결과를 다음 표7에 표시한다.Strains selected from the culture and the control strains were inoculated at 1% level and then cultured in an incubator at 37 ℃. Take 100 µl of the culture solution for 1, 3, 8, and 12 hours at the start of the culture, dilute it in the anaerobic dilution solution according to the method of Mitsoka, and smear it on a BL solid medium and incubate anaerobicly for 36 to 48 hours in an anaerobic vessel. The number was measured. The bile resistance of each strain was compared with the change in viable cell counts. The results are shown in Table 7 below.

[실시예 6]Example 6

우유 배지에서의 배양 시험Culture test in milk medium

실시예 1에서 선발된 균주 및 대조균주를 10% 탈지우유에 0.05%의 cysteine·HCl을 첨가하여 제조한 우유배지에 1% 수준으로 접종하였다. 접종후 37℃의 항온 배양기에서 72시간 동안 배양하면서 매 12시간마다 배양액을 취해 BL 고체배지에 도말하고 혐기적으로 배양하여 생균수를 측정하였다. 결과를 다음 표8에 표시한다.The strains and control strains selected in Example 1 were inoculated at a 1% level in milk medium prepared by adding 0.05% cysteine-HCl to 10% skim milk. After inoculation, the culture medium was taken every 12 hours while incubating for 72 hours at 37 ° C. incubator, plated on BL solid medium, and cultured anaerobicly to measure the number of viable cells. The results are shown in Table 8 below.

상기 시험 결과에서 보는 바와 같이, 본 발명의 방법에 따라 자연물로부터 비피도박테리움을 스크리닝하였을 때 내산성(acid tolerance 및 acid resistance) 및 내담즙성을 갖는 균주를 효과적으로 분리할 수 있다. 특히 본 발명에 따라 분리한 균주는 약산성에서의 증식성(acid tolerance)과 강산성에서의 생존성(acid reaistance)을 나타낸다.As can be seen from the test results, when screening Bifidobacterium from natural products according to the method of the present invention, it is possible to effectively isolate strains having acid resistance (acid tolerance and acid resistance) and bile resistance. In particular, the strain isolated according to the present invention exhibits acid tolerance and acid reaistance in strong acidity.

또한 우유배지에서 배양한 실험 결과에서, 균체의 증식에 따라 배재내에 분해산물이 축적됨으로써 생존 환경이 악화되어도 본 발명에 따라 분리된 균주(HJ, Sl, SJ)는 일반적인 분리방법으로 분변에서 직접 취해진 l1, j1에 비해서 높은 생존력을 나타냄을 알 수 있다.In addition, in experimental results cultured in milk medium, even if the survival environment worsens due to the accumulation of degradation products in the embryo as the cells grow, the strains isolated according to the present invention (HJ, Sl, SJ) were taken directly from the feces by the general separation method. It can be seen that the viability is higher than that of l1 and j1.

이상 설명에서 명백한 바와같이, 본 발명의 분리방법에 의해서 인체에 유익작용을 하는 비피도박테리움중에서도 특히 내산성과 내담즙성을 갖는 균주를 용이하게 얻을 수 있다. 이와 같은 본 발명의 방법에 따라 분리된 균주는 사람이 경구적으로 섭취하였을 때 소화관 내에서의 가혹한 pH 조건과 급격한 pH의 변화 그리고 각종 소화효소에 대한 내성을 발휘함과 함께 장내 정착률이 높으므로, 본 발명의 방법에 따라 분리된 균주는 각종 비피더스 발효제품의 종균으로 사용될 수 있다.As evident from the above description, the strain of the present invention can easily obtain strains having acid and bile resistance, especially among Bifidobacterium which has a beneficial effect on the human body. Since the strain isolated according to the method of the present invention orally ingested by humans exhibits severe pH conditions and rapid pH changes in the digestive tract and resistance to various digestive enzymes, and has a high intestinal fixation rate, The strain isolated according to the method of the present invention can be used as a seed of various bifidus fermented products.

Claims (3)

자연물을 혐기조건하에 비피도박테리움 선택배지에 접종하여 배양하고, 상기 얻어진 배양액을 다시 최적 비피도박테리움 선택배지에 재접종하여 강화 계대배양함으로써 생균수를 증가시키고, 얻어진 강화배양된 배양액을 강산성으로 조절된 비피도박테리움 선택배지에 접종하여 배양하고, 상기 산성 배지에서 얻어진 배양액을 약산성으로 조절된 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액을 최적 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액에서 생존 비피도박테리움의 존재를 확인하고, 상기 배양액을 고농도 담즙이 함유된 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액을 저농도 담즙이 함유된 비피도박테리움 선택배지에 접종하여 배양하고, 얻어진 배양액으로부터 생존 비피도박테리움을 분리하는 단계를 포함하는 내산성 및 내담즙성 비피도박테리움의 분리방법.Natural products were inoculated in Bifidobacterium selective medium under anaerobic conditions, and the obtained culture was reinoculated into optimal Bifidobacterium selective medium to increase the number of viable cells by fermentation, and the obtained culture was strongly acidified. Inoculated and incubated in a Bifidobacterium selective medium, and the culture medium obtained from the acidic medium was inoculated into a Bifidobacterium selection medium adjusted to weak acidity, and the obtained culture was inoculated in an optimal Bifidobacterium selection medium. And cultured by confirming the presence of viable Bifidobacterium in the culture medium obtained, inoculating the culture medium into Bifidobacterium selective medium containing high concentration of bile, and cultivating the obtained culture medium with Bifidobacterium containing low concentration of bile. Inoculated and cultured in selective medium, surviving Bifidobacterium from the culture medium obtained Comprising the step of separating acid and bile-magnetic separation method of Bifidobacterium. 제1항에 있어서, 상기 자연물이 인간의 분변임을 특징으로 하는 방법.The method of claim 1 wherein the natural product is human feces. 제1항 또는 제2항에 있어서, 상기 비피도박테리움 선택배지가 TP 배지임을 특징으로 하는 방법.The method according to claim 1 or 2, wherein the Bifidobacterium selective medium is TP medium.
KR1019960007850A 1996-03-22 1996-03-22 Separation method for bifidobacterium which has acid tolerance KR0157757B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019960007850A KR0157757B1 (en) 1996-03-22 1996-03-22 Separation method for bifidobacterium which has acid tolerance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960007850A KR0157757B1 (en) 1996-03-22 1996-03-22 Separation method for bifidobacterium which has acid tolerance

Publications (2)

Publication Number Publication Date
KR970065706A KR970065706A (en) 1997-10-13
KR0157757B1 true KR0157757B1 (en) 1998-10-15

Family

ID=19453674

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960007850A KR0157757B1 (en) 1996-03-22 1996-03-22 Separation method for bifidobacterium which has acid tolerance

Country Status (1)

Country Link
KR (1) KR0157757B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109136138A (en) * 2018-11-18 2019-01-04 善恩康生物科技(苏州)有限公司 The method and dedicated culture medium, corresponding method of counting of Bifidobacterium are cultivated in standard incubator

Also Published As

Publication number Publication date
KR970065706A (en) 1997-10-13

Similar Documents

Publication Publication Date Title
JP2992945B2 (en) Lactobacillus acidophilus lactic acid bacteria
US4187321A (en) Method for producing foods and drinks containing bifidobacteria
KR101141781B1 (en) Method for producing fermented milk using novel lactic acid bacteria
US20230034193A1 (en) Bifidobacterium animalis subsp. lactis i797, method for separation and purification thereof, and use thereof
Collins et al. Growth of bifidobacteria in milk and preparation of Bifidobacterium infantis for a dietary adjunct
Matteuzzi et al. Bifidobacterium suis n. sp.: A new species of the genus Bifidobacterium isolated from pig faces
CN110577912B (en) Lactobacillus gasseri and application thereof in preparing fermented milk
MX2008009568A (en) Novel lactic acid bacteria.
EP0111392B1 (en) A culture containing viable cell mass of bifidobacteria and lactic acid bacteria, and a process for preparing said culture
JPH0468908B2 (en)
CN116286468A (en) Lactobacillus mucilaginosus LF-ONLLY with antioxidant function and application thereof in fermented food
CN110157650A (en) The bifidobacterium lactis M8 of one plant of isolated from mother's milk and its application
JPH0687732B2 (en) Method for producing fermented milk containing bifidobacteria
WO2010074465A1 (en) Strain stimulating the growth of bifidobacterium sp
KR100264361B1 (en) Lactobacillus plantarum PMO08 (KFCC-11028) with cholesterol lowering ability
EP0112020B1 (en) A new microorganism belonging to streptococcus thermophilus and a composition containing said microorganism
KR100609779B1 (en) Lactic acid bacteria degrading alcohol and acetaldehyde
KR0157757B1 (en) Separation method for bifidobacterium which has acid tolerance
CN109022330A (en) One plant has high proteolytic ability and produces Lactococcus lactis BL19 and its application of junket fragrance
KR100299306B1 (en) Lactic acid bacteria with high acid resistance and growth rate and excellent blood cholesterol lowering ability
JP4794592B2 (en) New lactic acid bacteria
Rada Effect of Kluyveromyces marxianus on the growth and survival of bifidobacteria in milk
KR0142615B1 (en) New Lactic Acid Bacteria with Excellent Acid Resistance and Cholesterol Degradation Isolated from Feces of Korean Infant and Their Use
JPH05236945A (en) New bacterium belonging to genus lactobacillus
RU2816652C1 (en) Bacterial strain lacticaseibacillus paracasei subspecies paracasei 1338 vkm b-3753d for production of fermented milk products and as probiotic

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060706

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee